Company
Management
Christophe Thurieau
Chief Executive Officer
Executive Director of Research Institute and Global Head of External Research at Servier- In his rol… Read moree at Servier , Dr Christophe Thurieau is leading Servier’s Research centers and as head of external Research he is responsible for World Wide Research hubs to establish external strategic partnerships in R&D. Before joining Servier in April 2017 Dr Christophe Thurieau worked at Ipsen from 1996 to 2017. After different increasing roles and responsibilities within Research and Development at Ipsen, he was since 2009 President Ipsen Innovation and Senior Vice –President Global Scientific Affairs at Ipsen. He has authored more than 30 original research articles in international peer-reviewed scientific journal and holds 25 patents. Dr Christophe Thurieau obtained pre and post-doctoral training at Harvard medical school, Boston (U.S.) and received his Ph.D. in biochemistry from University Pierre and Marie Curie, Paris VI in 1988.
Jane Juel
Interim Chief Operating Officer (VP, Head of People&Faciity)
Jane Juel, MA Int Business Comms, is a Danish national, born in 1971.
She joined the company … Read morein 2024.
Prior to joining the company, Jane Juel brings more than 20 years of biotech and pharma experience working across HR, Global Facility and Administration and Clinical Development.
Jane Juel has held various leadership positions in companies like Dansk Standard, Implement and Genmab.
She joined the company … Read morein 2024.
Prior to joining the company, Jane Juel brings more than 20 years of biotech and pharma experience working across HR, Global Facility and Administration and Clinical Development.
Jane Juel has held various leadership positions in companies like Dansk Standard, Implement and Genmab.
Claus Haase, Ph.D
SVP, Head of Biologic Drug Design
Claus Haase, Ph.D, is a Danish national, born in 1976.
He joined the company in 2023 and has… Read more previously held leadership positions in Novo Nordisk A/S, Ferring Pharmaceuticals and LEO Pharma.
He joined the company in 2023 and has… Read more previously held leadership positions in Novo Nordisk A/S, Ferring Pharmaceuticals and LEO Pharma.
Rikke Bolding Jensen, M.Sc, Ph.D,
Director, Head of CMC Biologics
Rikke Bolding Jensen, M.Sc, Ph.D, is a Danish national, born in 1969. She joined the company in 201… Read more4.
Before joining the company, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Before joining the company, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Michael Herbst
VP, Finance and Procurement
Michael Herbst is a Danish national, born in 1972. He joined the company in 2023.
He … Read moreholds a Graduate Diploma in Business Administration (Finance & Management) from Copenhagen Business School. Prior to joining the company, Michael Herbst held various management positions in finance and administration in companies such as Maersk Air Cargo, Stryhns, Ferrosan Medical Devices and Ferring Pharmaceuticals.
He … Read moreholds a Graduate Diploma in Business Administration (Finance & Management) from Copenhagen Business School. Prior to joining the company, Michael Herbst held various management positions in finance and administration in companies such as Maersk Air Cargo, Stryhns, Ferrosan Medical Devices and Ferring Pharmaceuticals.